| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |